Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$577,943
+$122,366 QoQ
Shares Held
10,622
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#407
of 751 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PURSUE WEALTH PARTNERS LLC holds $1,312,865 across 4 Biotechnology names. EXEL ranks #1 (44.0% of the industry book) .
All Filings in EXEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $577,943 | 10,622 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $455,577 | 10,622 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $465,562 | 10,622 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $438,688 | 10,622 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $468,217 | 10,622 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $392,164 | 10,622 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $353,712 | 10,622 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $353,490 | 13,622 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $306,086 | 13,622 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $325,101 | 13,700 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $328,663 | 13,700 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $349,600 | 16,000 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $305,760 | 16,000 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $310,560 | 16,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $256,640 | 16,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $250,880 | 16,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $333,120 | 16,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $362,720 | 16,000 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $292,480 | 16,000 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||